Your weekly roundup of the latest news from Drug Topics®.
Pharmacists can make simple changes that add up to big environmental impacts.
Pharmacists can play an important role in patients’ wellness journeys.
The Breakthrough Therapy designation for VAX-24 will grant Vaxcyte access to the FDA’s Fast Track program.
With the respiratory season in full swing and COVID-19 continuing to infect, knowing the basics of the common cold, influenza, COVID-19, and respiratory syncytial virus can help ensure patients get the right care.
Clarivate analysts have identified the treatments they forecast could deliver annual sales of more than $1 billion within 5 years. These include therapies for rare diseases, as well as HIV, Parkinson’s disease, Crohn’s disease, alopecia, and cancer.
Podcast: Discussing the Shared Central Fulfillment Solution with iA
May 6th 2024Brian Nowosielski, associate editor with Drug Topics, sat down with Tom Utech and Reed Richardson of iA, an innovative pharmacy fulfillment company. Utech, CEO of iA, and Richardson, Chief Commercial Officer of iA, discussed the company's new shared central fulfillment solution. The new solution, designed to streamline processes within the pharmacy, is a technological innovation with life-saving benefits for patients.